The Enterprise Value as of September 2024 (TTM) for Aridis Pharmaceuticals, Inc. (ARDS) is 1.44M

According to Aridis Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.44M. This represents a change of -90.21% compared to the average of 14.71M of the last 4 quarters.

Aridis Pharmaceuticals, Inc. (ARDS) Historical Enterprise Value (quarterly & annually)

How has ARDS Enterprise Value performed in the past?

The mean historical Enterprise Value of Aridis Pharmaceuticals, Inc. over the last ten years is 38.76M. The current 1.44M Enterprise Value has changed 271.38% with respect to the historical average. Over the past ten years (40 quarters), ARDS's Enterprise Value was at its highest in in the June 2018 quarter at 89.10M. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Aridis Pharmaceuticals, Inc. (ARDS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aridis Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aridis Pharmaceuticals, Inc. (ARDS) Average Enterprise Value

How has ARDS Enterprise Value performed in the past?

The current Enterprise Value of Aridis Pharmaceuticals, Inc. (ARDS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aridis Pharmaceuticals, Inc. (ARDS) Enterprise Value vs. Peers

How is ARDS’s Enterprise Value compared to its peers?

Aridis Pharmaceuticals, Inc.’s Enterprise Value is less than Akari Therapeutics, Plc (34.96M), less than Aditxt, Inc. (9.56M), less than ABVC BioPharma, Inc. (10.19M), less than Acasti Pharma Inc. (8.19M), less than Sigilon Therapeutics, Inc. (43.98M), less than Reviva Pharmaceuticals Holdings, Inc. (40.92M), less than ZyVersa Therapeutics, Inc. (2.49M), less than Kiromic BioPharma, Inc. (11.80M), less than Unicycive Therapeutics, Inc. (42.09M), greater than Avenue Therapeutics, Inc. (-1054328.00), greater than Hoth Therapeutics, Inc. (-2640895.00), greater than Revelation Biosciences, Inc. (-10649882.00), greater than NeuroBo Pharmaceuticals, Inc. (1.09M), less than Virax Biolabs Group Limited (8.31M), less than Reviva Pharmaceuticals Holdings, Inc. (40.92M), less than Eyenovia, Inc. (51.85M), greater than Cognition Therapeutics, Inc. (-3865344.00), less than TransCode Therapeutics, Inc. (2.92M), less than Kodiak Sciences Inc. (96.49M), greater than Dermata Therapeutics, Inc. (-1986143.00),

Build a custom stock screener for Aridis Pharmaceuticals, Inc. (ARDS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aridis Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aridis Pharmaceuticals, Inc. (ARDS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aridis Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.